The pattern of cervical cancer screening in Hong Kong by Yanova, J et al.
Title The pattern of cervical cancer screening in Hong Kong
Author(s) Adab, P; McGhee, SM; Yanova, J; Wong, LC; Wong, CM; Hedley,AJ
Citation Hong Kong Medical Journal, 2006, v. 12 n. 4 Suppl 2, p. S15-S18
Issued Date 2006
URL http://hdl.handle.net/10722/57375
Rights Creative Commons: Attribution 3.0 Hong Kong License
Hong Kong Med J Vol 12 No 4 Supplement 2 August 2006     15
HEALTH SERVICES RESEARCH FUND – HEALTH CARE AND PROMOTION FUND
Hong Kong Med J 2006;12 (Suppl 2):S15-8
The pattern of cervical cancer screening
in Hong Kong
○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○
Department of Community Medicine, The
University of Hong Kong
P Adab, SM McGhee, J Yanova, LC Wong,
CM Wong, AJ Hedley
HSRF project number: 711023
Principal applicant and corresponding author:
Dr P Adab
Dept of Community Medicine & Unit for
Behavioural Sciences, 5/F, William MW
Mong Block, Faculty of Medicine, The
University of Hong Kong, 21 Sassoon Road,
Hong Kong SAR, China
Present address:
Department of Public Health &
Epidemiology, The University of
Birmingham, 162 Viceroy Close, Edgbaston,
Birmingham, B5 7UX, UK
Tel: (44) 121 414 3777
Fax: (44) 121 414 7878
E-mail: p.adab@bham.ac.uk
P Adab  
SM McGhee  
J Yanova  
LC Wong  
CM Wong  
AJ Hedley  Background
Cervical cancer is an important cause of morbidity and mortality among women
worldwide.1 Compared to other developed countries, Hong Kong has a
moderately high mortality rate for cervical cancer,2 and is cited as a ‘high risk’
area for this by the International Agency for Cancer Research.3 Despite good
evidence that effective prevention can be provided by screening,4 not all women
attend and Hong Kong has no organised screening programme. There has
been much research investigating reasons for screening attendance and non-
attendance in different communities, and the factors associated with
uptake. However, few have been done in Chinese populations. Although many
industrialised countries have adopted organised screening programmes, this is
by no means universal. Reported uptake of screening in regions with no
organised programme varies widely and there are few studies formally
comparing ad-hoc with organised programmes.
Aims and objectives
This study aimed to determine the coverage and frequency of cervical
cancer screening among women in Hong Kong, describe the factors affecting
attendance and non-attendance for screening, and use this information to make
future policy decisions.
Methods
Study design
This was a cross-sectional study undertaken from August 1997 to May 1999,
using telephone interviewing to survey a random selection of Chinese women in
Hong Kong.
Subjects
Chinese women aged 20 years or older were included, and only those with a
previous hysterectomy were excluded. A randomly selected household was
contacted by phone, all eligible women in the household were identified and one
was randomly selected and invited to participate. The sample size was chosen to
allow estimation of coverage in three age bands (20-39, 40-59, ≥60 years). Only
after sufficient numbers in an age-group were obtained, women in the other
age-groups were then sampled. However, older women were still under-
represented and so interviews of elderly centre attendees were used to
supplement numbers in this group.
Study variables
The main outcome measure was coverage and frequency of Papanicolaou (Pap)
smear screening. Diagnostic Pap smears were differentiated from screening smears
by identifying those that were taken because of gynaecological symptoms or
following an abnormal result. Those taken as part of a routine or opportunistic
check-up were classed as screening smears. For those who had previously been
screened, other outcomes were the frequency and regularity of screening.
Respondents who had not been screened were asked about reasons for
non-attendance. Information on knowledge and attitudes towards cervical
cancer and screening, risk factors for cervical cancer, and perceived risk was
obtained.
Key Messages
1. Cervical cancer is an important
health problem in Hong Kong.
2. A large proportion (56%) of
women in Hong Kong do not
attend cervical cancer screening.
3. Those who are being screened
have lower risk and are screened
more frequently than necessary.
4. T h e  c u r r e n t  s y s t e m  i s
inadequate, inequitable, wastes
resources and may result in harm
due to over-screening low-risk
respondents.
5. Introduction of an organised
screening programme should
improve effectiveness and
efficiency.
6. To balance effectiveness and
efficiency, a 4- to 6-yearly
screening interval with target
coverage of 80% is a reasonable
option.
7. To be effective, an organised
programme should have high
coverage of target groups as its
main aim.
8. Introducing such a programme
would require commitment to
adequate long-term resources,
and development of agreed
policies for screening methods,
programme organisation, and
monitoring.
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Table. Effectiveness and efficiency of adopting various screening policies, targeting all or selected groups in the population,
and with varying screening interval and coverage (weighted for age, education levels, and living districts)
As the true incidence of cervical cancer in the absence of any screening was unknown, our estimation of benefits for organised
screening was based on incidence calculated by the optimistic model (*) and the pessimistic model (†) of current screening patterns
Organised screening system 60% coverage
Range for % reduction in incidence Range for No. of smears
(cases prevented) per case prevented
Screen all women with the following screening intervals
0-11 months 48.4 -  56.1*† (307† - 329*) *4200* - 4500†
12-23 months 48.4 -  55.5*† (304† - 326*) *2123* - 2275†
24-35 months 48.4 -  54.5*† (298† - 320*) *1442* - 1545†
36-47 months 48.4 -  52.3*† (286† - 307*) *1127* - 1208†
48-71 months 48.4 -  50.2*† (275† - 294*) *0939* - 1007†
72-119 months 48.4 -  42.8*† (234† - 251*) *0688* - 738†0
≥120 months 48.4 -  22.5*† (123† - 132*) *0698* - 748†0
Age <40 ad hoc and age >40 with 3-4 yrs screening interval 48.4† - 49.4* (265† - 290*) **1279† - 1399*
No screening for age <40 and age >40 with 3-4 yrs screening interval 41.0* - 41.1† (225† - 240*) 0069†* - 738†0
Private ad hoc plus 3-4 yrs organised screening for those 56.1† - 57.7* (307† - 338*) *1378† - 1379*
insufficiently or never screened
Current screening system*
Optimistic* 31.1 (183) 2492
Pessimistic† 26.2 (144) 2018
Data analysis
Coverage and frequency of cervical screening
The coverage and screening frequency obtained was used
to estimate the effectiveness (number of cases of invasive
cervical cancer potentially prevented) and efficiency (tests
per case prevented) of the current screening system. This
was done by applying the estimated benefits of screening
reported by a published analysis of data from large
screening programmes in the west.5 When respondents
had had two negative screens in the past, we assumed they
would have some benefit. To classify their level of benefit,
we determined the likely interval till their next screen.
When this was unknown, we modelled it based on
pessimistic (next screen will be 10 years or more after the
last one) and optimistic (next screen will take place soon)
assumptions.
Factors affecting attendance and non-attendance for
screening
The associations between screening behaviour and several
factors, including socio-demographic and behavioural
factors, perceived risk, and knowledge and attitude towards
screening were examined. Reasons for non-attendance and
barriers to screening were described.
Informing future policy
Potential effectiveness and efficiency of various organised
programmes with different screening intervals and
coverage were estimated and compared with the current
system.
Results
Characteristics of the sample
A total of 1826 women between the ages of 20 and 77 years
were interviewed, with an overall response rate of 61.6%.
The 584 women in the 20-to-39–year age band were
selected using only random digit dialling, and were similar
in level of education and district of residence to the general
population in that age-group. The other women were
recruited partly through random digit dialling and partly
through targeted sampling. In these groups, women with a
lower level of education and those living in Kowloon are
relatively under-represented. Where population estimates
are given in subsequent analyses, weighting to compensate
for under-representation of sub-groups has been used.
Coverage and frequency of screening
Excluding 111 (6.1%) women who had never had sexual
intercourse, 792 (46.3%) respondents had ever had a Pap
smear. This included 54 (6.8% of all tested) who had
diagnostic smears. Thus screening coverage in this
population was 43.1%. This is equivalent to coverage of
44.4% for all eligible women in Hong Kong (ie those
over 20 years old with a previous sexual history), after
standardising to the age structure of women in the region.
Among the respondents who have ever had a screening
test in their lifetime, 160 (9.4%) had only had one such test
and only 427 (25.0%) attended for regular screening. The
majority of regular attendees (80.8%) attended at least once
per year and 99% attended at least 3 yearly. The maximum
screening interval was 3 to 4 years. A proportion (5.5%)
attended for screening more than once per year.
Factors affecting attendance for screening
The majority of respondents had good knowledge about
the risk of cervical cancer and the benefits of screening.
Respondents who had previously had a screening test had
significantly higher mean knowledge scores (1.44 and 1.30
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respectively, t= -3.0, P=0.003) and attitude scores (0.87 and
0.34 respectively, t= -8.4, P<0.001).
The reasons given for non-attendance were varied. The
most common reasons were that respondents did not think
they needed to, or that they did not know what the test was
for. Apart from these, the most commonly reported reason
for non-attendance was lack of time. Respondents who
perceived the test as unnecessary, who did not want it or
did not know what it was for, tended to be older. Fear,
anxiety, pain, and humiliation appeared to be more
common reasons among younger respondents. When asked
about factors that would make it easier to attend for
screening, the most common suggestion was increased
publicity and education.
All respondents were asked how likely they were to
attend for Pap screening in the future. Nearly two thirds
stated that they were likely or very likely to attend.
Respondents, who said they were unlikely or very unlikely
to attend, tended to be older, in lower social class groups,
and single. They were also less likely to have had a
previous Pap smear, had less knowledge about cervical
cancer and screening, and were less likely to believe they
were personally at risk of cervical cancer. They were
significantly more likely to think the test would be
embarrassing and expect the clinical atmosphere to be
cold and less likely to believe having a test would give them
peace of mind.
Respondents who had been screened for cervical cancer,
and who were regular attendees, were more likely to have
lower risk for disease. Thus, they tended to be younger,
non-smokers, in the higher social groups, and to have used
the oral contraceptive pill. Only 38.4% of respondents
perceived their own risk of cervical cancer as low. There
was a significant positive association between higher
perceived risk and history of screening. There was also a
significant increasing trend in the likelihood of having
had a screening test with increasing levels of reported
worry associated with cervical cancer. In summary, there
was no relationship between objective risk and perceived
risk, but perceived risk was a better predictor of previous
screening.
Using a logistic regression model to explore factors
associated with screening uptake in the last 5 years, we found
that women who were younger, in higher socio-economic
groups, and married were more likely to have attended for
screening. About half the responders were born in Hong
Kong. The rest were mainly born in Mainland China, though
4.8% were born in other Asian countries, and 0.2% in the
west. Those born in Hong Kong were more  likely to have
attended for screening. Within Hong Kong, those living in
Kowloon were least likely to have attended for screening.
Women who had attended for cervical screening, were also
more likely to have attended for a mammogram, to have
regular dental check-ups, and to have never smoked.
Informing policy
Based on the Hong Kong population age-sex structure and
age-group–specific incidence for cervical cancer in 1997,
we estimated the potential percentage reduction in incidence
of cervical cancer and the number of cases prevented in the
present system of screening in Hong Kong. At best, the
present system is likely to have prevented about 31.1% (183
cases), and more realistically, 26.2% (144 cases) of all
potential new cases of invasive cancer.
We examined the effects of introducing various
80% coverage
Range for No. of Pap Range for % reduction in incidence Range for No. of Range for No. of Pap
smear tests/year (cases prevented) smears per case prevented smear tests/year
1 381 800*† 62.1 - 74.8*† (409† - 439*) 4200* - 4500† 1 842 400*†
0 690 900*† 62.1 - 74.0*† (405† - 434*) 2123* - 2275† 0 921 200*†
0 460 600*† 62.1 - 72.6*† (398† - 426*) 1442* - 1545† 0 614 133*†
0 345 450*† 62.1 - 69.7*† (381† - 409*) 1127* - 1208† 0 460 600*†
0 276 360*† 62.1 - 66.9*† (366† - 392*) 0939* - 1007† 0 368 480*†
0 172 725*† 62.1 - 57.0*† (312† - 335*) 0688* - 738†0 0 230 300*†
0 092 120*† 62.1 - 30.0*† (164† - 176*) 0698* - 748†0 0 122 827*†
338 710† - 405 588* 62.1† - 63.1* (340† - 370*) 1160† - 1246* 394 045† - 460 923*
0 166 005*† 54.6* - 54.8† (300† - 320*) 0691* - 738†0 0 221 340*†
422 914† - 466 397* 71.1† - 72.6* (389† - 426*) 1319* - 1333† 518 675† - 562 009*
454 736 - - -
289 238 - - -
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organised screening programmes, and compared these with
the current situation (Table). A programme with target
coverage of 80% and a 3-to-4 yearly screening interval,
would achieve a nearly 70% reduction in cervical cancer
incidence. More frequent screening would lead to only a
small increase in effectiveness (5% lower incidence), with
a fall in efficiency (4-fold increase in smears). Extending
the screening interval to 4 to 6 years would only lead to a
small decrease in effectiveness (about 3%, 15 cases),
while the efficiency would increase by a further 20%.
A programme with 80% coverage and a 3-to-4 yearly
screening interval would achieve more than double the
benefit of the current system in terms of reduction of
incidence (55% versus 26% with the current system).
Discussion
This was a large study of a representative sample of Hong
Kong Chinese women in different age-groups, regarding
their knowledge, attitudes, and screening practice in
relation to cervical cancer.
Screening coverage
Our finding of 43% ever-screening coverage is likely to
be an overestimate, and the proportion who are regular
attendees are probably less than a quarter of all women.
Analysis of screening programmes in the European
Union found that coverage of 3-yearly screening varied
from 50 to 82%.5 Generally higher coverage is reported in
countries with centrally organised screening. Screening
coverage was lowest among women over the age of 60 years.
Factors associated with screening uptake
In this study population, screening uptake was higher among
younger women, those in higher socio-economic groups,
those who engage in other health promoting behaviour,
and those who perceive that they are personally at risk of
cervical cancer. Lack of knowledge about the Pap test and
not perceiving it as necessary were the major reasons
for non-uptake of screening. In countries where there is
organised screening, not wanting to attend or believing
that screening is unnecessary also account for a large
proportion of non-attendance.6 Those with more risk
factors were less likely to have been screened. However,
perceived risk was closely related to screening attendance.
Personal susceptibility has been shown to be a motivator
for screening attendance in other studies and there is
evidence that educational messages to change risk
perception can result in behaviour change.
Effectiveness and efficiency of screening
An organised screening programme aiming to achieve at
least 80% coverage across all age-groups would be most
effective. A less effective but more efficient system would
target those over 40 years old. Effectiveness increases with
increasing coverage whilst reducing the screening interval
has less effect. The current system of ad-hoc screening in
Hong Kong is likely to be less effective than we would
expect from an organised 10-yearly screening programme
achieving a low coverage of 60%. The current system is
also inefficient, with 20 to 25% of women being over-
screened. Our findings are consistent with other studies,
suggesting that targeting older women would be very
efficient and quite effective. An organised system would
improve the efficiency and cost effectiveness of screening
in terms of Pap smears per case prevented.
Conclusion
The current cervical screening system achieves poor
coverage, is inequitable, wastes resources, and may result
in more harm as a result of over-screening low-risk women.
It is also less effective and efficient than organised
programmes elsewhere. Special attention should be
focused on encouraging uptake among older women.
Based on our findings, maximum effectiveness at best
efficiency would occur with a 4-to-6 yearly screening
interval. A shorter screening interval would increase
effectiveness by up to 5% (yearly screening), but at 5 times
the cost. Since lack of knowledge about the Pap smear
was the main reason for non-attendance, women need to be
offered more information on Pap screening, its benefits
and potential harms to be able to make informed choices
about screening.
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